Literature DB >> 2119917

Cord blood B cells are mature in their capacity to switch to IgE-producing cells in response to interleukin-4 in vitro.

G Pastorelli1, F Rousset, J Pène, C Peronne, M G Roncarolo, P A Tovo, J E de Vries.   

Abstract

Neonatal B cells have been considered immature because of their impaired capacity to produce immunoglobulins in response to polyclonal activators in vitro. Here we demonstrate that cord blood mononuclear cells (MNC) produce normal levels of IgE in vitro when cultured in the presence of interleukin-4 (IL-4), indicating that the B cells are mature in their capacity to switch to IgE-producing cells. However, in contrast to adult peripheral blood T cells, cord blood T cells failed to produce detectable levels of IL-4 upon activation by phytohaemagglutinin (PHA) concanavalin A (Con A) or combinations of PHA and the phorbol ester TPA. Interferon-gamma (IFN-gamma) production by cord blood T cells following activation by Con A or PHA was also strongly reduced. However, high levels of IFN-gamma, significantly higher than those produced by adult T cells, were synthesized in response to combinations of PHA and TPA, indicating that IFN-gamma production by cord blood T cells is not intrinsically defective. In contrast, cord blood T cells produced levels of IL-2 that were significantly higher than those obtained by adult T cells tested in parallel. Collectively, our data indicate that the minimal levels of IgE production measured in cord blood (less than 1 U/ml) are not due to immaturity of the cord blood B cells, but may be associated with the failure of cord blood T cells to produce detectable levels of IL-4, which has been shown to be responsible for induction of IgE synthesis both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119917      PMCID: PMC1535178          DOI: 10.1111/j.1365-2249.1990.tb05413.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Active thymus derived suppressor lymphocytes in human cord blood.

Authors:  M B Oldstone; A Tishon; L Moretta
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

2.  Lymphocyte subpopulations in the blood of newborn infants.

Authors:  A C Campbell; C Waller; J Wood; A Aynsley-Green; V Yu
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

3.  Lymphocytes from human newborns abrogate mitosis of their mother's lymphocytes.

Authors:  L B Olding; M B Oldstone
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

4.  Deficiency of immune interferon production by leukocytes of normal newborns.

Authors:  Y J Bryson; H S Winter; S E Gard; T J Fischer; E R Stiehm
Journal:  Cell Immunol       Date:  1980-09-15       Impact factor: 4.868

5.  Newborn T cell suppression: early appearance, maintenance in culture, and lack of growth factor suppression.

Authors:  A R Hayward; J Kurnick
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

6.  Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E.

Authors:  N Wakasugi; J L Virelizier; F Arenzana-Seisdedos; B Rothhut; J M Huerta; F Russo-Marie; W Fiers
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

7.  Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma.

Authors:  I Chrétien; J Pène; F Brière; R De Waal Malefijt; F Rousset; J E De Vries
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

8.  Ontogeny of human cell-mediated immunity: age-related variation of in vitro infantile lymphocyte transformation.

Authors:  R H Alford; B B Cartwright; S H Sell
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

9.  IL-4 is required to generate and sustain in vivo IgE responses.

Authors:  F D Finkelman; I M Katona; J F Urban; J Holmes; J Ohara; A S Tung; J V Sample; W E Paul
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

10.  Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage.

Authors:  S Taylor; Y J Bryson
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  6 in total

1.  In vivo expression of human immunoglobulin germ-line mRNA in normal and in immunodeficient individuals.

Authors:  K B Islam; B Baskin; B Christensson; L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

2.  The antigen receptor complex on cord B lymphocytes.

Authors:  P J Macardle; H Weedon; M Fusco; S Nobbs; J Ridings; L Flego; D M Roberton; H Zola
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

3.  High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.

Authors:  M Yu; S Fredrikson; J Link; H Link
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

4.  Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.

Authors:  P Han; T McDonald; G Hodge
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

Review 5.  Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.

Authors:  Angelina Mimoun; Sandrine Delignat; Ivan Peyron; Victoria Daventure; Maxime Lecerf; Jordan D Dimitrov; Srinivas V Kaveri; Jagadeesh Bayry; Sébastien Lacroix-Desmazes
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561

6.  Selection of a human T helper type 1-like T cell subset by mycobacteria.

Authors:  J B Haanen; R de Waal Malefijt; P C Res; E M Kraakman; T H Ottenhoff; R R de Vries; H Spits
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.